The FDA has urged physicians to stop performing power morcellation to address uterine fibroids in women because the procedure may spread malignant tissue. The procedure is used to break up uterine fibroids and in surgeries to remove the uterus, but it may also spread cancerous tissue in cases where the women have previously undetected sarcomas, a situation that may occur in as many as 1 in 350 women who undergo hysterectomy or uterine fibroid removal.

Related Summaries